Methods for monitoring changes in the core of lipoprotein particles in metabolism and disease
Inventors
Cistola, David P. • Robinson, Michelle
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
A method is disclosed for measuring the properties of protein and lipoprotein elements in a sample. The method includes the of placing a small volume of a sample into a NMR instrument tuned to measure a particular nucleus;, applying a series of radio frequency pulses with intermittent delays in order to measure spin-spin and/or spin-lattice relaxation time constants from the time-domain decay of the signal, without the use of chemical shifts and without converting data into the frequency domain by Fourier transform or other means, at least partially suppressing the water signal prior to the beginning of a sequence used to record relaxation time constants in the time domain, optionally utilizing relaxation contrast agents or other chemical additives to perturb the solvent water or other elements of the sample, analyzing the exponentially decaying NMR signal in the time domain using multi-exponential analysis, and comparing differences in the relaxation time constants for lipoprotein- or protein-specific elements within a single human subject, or between subjects, to assess normal and abnormal metabolism reflective of increased disease risk or active disease.
Core Innovation
The disclosed method measures dynamical, mobility, fluidity, and physical properties of protein and lipoprotein elements, including lipoprotein particle core and surface mobility and relative core and surface composition. It analyzes time-domain NMR relaxation signals using multi-exponential analysis, including an inverse Laplacian transform, without using chemical shifts or converting data into the frequency domain.
The method compares relaxation time constants for protein- or lipoprotein-specific elements within one subject or between subjects to assess normal and abnormal metabolism associated with disease risk or active disease. The partial content identifies cardiovascular and metabolic risk assessment as potential uses. It does not include the background section, so the problem stated in that section is not explicitly described in patent.
Claims Coverage
The two independent claims cover two inventive features: time-domain NMR analysis of protein and lipoprotein properties, and a whole-blood-derived plasma or serum implementation of that analysis.
Time-domain NMR analysis of protein and lipoprotein properties
Claim 1 covers measuring protein and lipoprotein mobility, fluidity, and physical properties by analyzing time-domain NMR relaxation signals with multi-exponential analysis, without chemical shifts or frequency-domain conversion, and comparing relaxation time constants to assess metabolism and disease risk.
Analysis of plasma or serum derived from whole blood
Claim 13 covers measuring protein and lipoprotein properties in plasma or serum derived from a patient's whole-blood specimen, using time-domain NMR relaxation analysis and comparison of relaxation time constants to assess metabolism and disease risk.
Together, the independent claims cover time-domain NMR measurement and analysis of protein and lipoprotein properties, and comparison of relaxation time constants for metabolic assessment, with the second claim specifying plasma or serum derived from whole blood.
Stated Advantages
The method can use simpler, lower-cost benchtop NMR instruments.
Documented Applications
Assessment of cardiovascular and metabolic risk, including assessment of metabolism associated with early insulin resistance syndrome, prediabetes, metabolic syndrome, type 1 and type 2 diabetes, and other metabolic disorders.
Interested in licensing this patent?